← Open Payments lookup

AMANDA BOYD: Open Payments

NPI 1447640321 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,068 in 130 payments from 18 companies in 2025. Trend: 2023 $2,495 · 2024 $1,888 · 2025 $3,068

Food & beverage: $2,959Education: $109
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.17$649
Neurocrine BioSciences, Inc.15$468
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)26$431
Teva Pharmaceuticals USA, Inc.16$332
Axsome Therapeutics, Inc.5$219
ABBVIE INC.19$186
Otsuka America Pharmaceutical, Inc.5$118
Takeda Pharmaceuticals U.S.A., Inc.5$116
Supernus Pharmaceuticals, Inc.6$115
E.R. Squibb & Sons, L.L.C.3$86

Products named: FANAPT, INGREZZA, CAPLYTA, AUSTEDO XR, Auvelity, REXULTI, VRAYLAR, SPRAVATO.

Industry payments across AL — which companies pay providers there.